Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies
Walter Reinisch(Medical University of Vienna), Dirk Vanderschueren(KU Leuven), Vijay Rajendran(Galapagos (Belgium)), Ursula Seidler(Medizinische Hochschule Hannover), Rajiv Mehta(Amrita Institute of Medical Sciences and Research Centre), Sławomir Jeka, Radboud J. E. M. Dolhain(Erasmus MC), Radka Moravcová(Charles University), R. Besuyen(Galapagos (Belgium)), Oleksandr Golovchenko, Olena Garmish, В. И. Симаненков(North-Western State Medical University named after I.I. Mechnikov), Wayne J.G. Hellstrom(Tulane University), Sarah Arterburn(Gilead Sciences (United States)), Franck‐Olivier Le Brun, Timothy R. Watkins(Gilead Sciences (United States)), René Westhovens(KU Leuven), Timothy E. Ritter(Unknown), Suresh C. Sikka(Tulane University)
Cited by 44
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k